Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
AER-101 (University of Oklahoma) in Non-small cell lung cancer stage I: NCT07631299 Clinical Landscape Report 2026
15 October 2026
NCT07631299 clinical landscape for Non-small cell lung cancer stage I: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Doxercalciferol in Hypoparathyroidism: NCT07640347 Clinical Landscape Report 2026
15 October 2026
NCT07640347 clinical landscape for Hypoparathyroidism: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRXG-K-1939 in Locally Advanced Lung Non-Small Cell Carcinoma: NCT07652125 Clinical Landscape Report 2026
15 October 2026
NCT07652125 clinical landscape for Locally Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
FGFR2b ADC(AILUX) in Advanced Lung Non-Small Cell Squamous Carcinoma: NCT07638891 Clinical Landscape Report 2026
15 October 2026
NCT07638891 clinical landscape for Advanced Lung Non-Small Cell Squamous Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Metyrapone/Oxazepam in Metastatic Colorectal Carcinoma: NCT07649655 Clinical Landscape Report 2026
15 October 2026
NCT07649655 clinical landscape for Metastatic Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Almonertinib Mesilate in Advanced Lung Non-Small Cell Carcinoma: NCT07645222 Clinical Landscape Report 2026
15 October 2026
NCT07645222 clinical landscape for Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Ivonescimab in Advanced Lung Non-Small Cell Carcinoma: NCT07669051 Clinical Landscape Report 2026
15 October 2026
NCT07669051 clinical landscape for Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Tipiracil Hydrochloride/Trifluridine in Colorectal Cancer: NCT07656038 Clinical Landscape Report 2026
15 October 2026
NCT07656038 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Serplulimab in Squamous non-small cell lung cancer: NCT07647094 Clinical Landscape Report 2026
15 October 2026
NCT07647094 clinical landscape for Squamous non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
ACM-CpG(ACM Biolabs) in Adenocarcinoma of large intestine: NCT07658196 Clinical Landscape Report 2026
15 October 2026
NCT07658196 clinical landscape for Adenocarcinoma of large intestine: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Recaticimab in Mixed hyperlipidemia: NCT07674368 Clinical Landscape Report 2026
15 October 2026
NCT07674368 clinical landscape for Mixed hyperlipidemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cromolyn Sodium in Adenocarcinoma of Lung: NCT07675876 Clinical Landscape Report 2026
15 October 2026
NCT07675876 clinical landscape for Adenocarcinoma of Lung: endpoints, sponsor, phase, geography, readouts, asset context and development white space.